Minerva Neurosciences, Inc. (NERV)
2.56
+0.07
(+2.81%)
USD |
NASDAQ |
Nov 11, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Minerva Neurosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 74.59% |
| Tonix Pharmaceuticals Holding Corp. | 89.00% |
| Karyopharm Therapeutics, Inc. | 96.75% |
| Corbus Pharmaceuticals Holdings, Inc. | -- |
| Ocugen, Inc. | 71.91% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -351.7% |
| Return on Net Operating Assets | -1.96K% |